StepStone leads $670m multi-fund healthcare restructuring
Medical devices business Confluent accounted for a majority of NAV in a transaction involving Ampersand Capital Partners.
Medical devices business Confluent accounted for a majority of NAV in a transaction involving Ampersand Capital Partners.
Copyright PEI Media
Not for publication, email or dissemination